CAS: 152981-31-2 - Inolimomab
Fórmula:Unspecified
- Sinónimos:
- Inolimomab
- Immunoglobulin G1, anti-(human interleukin 2 receptor α-chain) (mouse monoclonal B-B10 γ1-chain), disulfide with mouse monoclonal B-B10 κ-chain, dimer
- Immunoglobulin G 1 (mouse monoclonal B-B10 γ-chain anti-human interleukin-2 receptor α-chain), disulfide with mouse monoclonal B-B10 κ-chain, dimer
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | Inolimomab REF: TM-T77036CAS: 152981-31-2 | - - - | A consultar | Ter 29 Out 24 |
 | Inolimomab REF: 3D-CLA1102CAS: 152981-31-2 | - - - | A consultar | Qua 06 Nov 24 |
Inolimomab
CAS:152981-31-2
Inolimomab, an anti-IL-2R α monoclonal antibody, shows promise in early aGVHD treatment studies.
Cor e Forma:
Solid
Ref: TM-T77036
| 5mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 29 de Outubro de 2024
Inolimomab
CAS:152981-31-2
A humanized anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody.
Ref: 3D-CLA1102
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Quarta-feira 6 de Novembro de 2024
